Chongkundang Holdings

종근당홀딩스 · 001630

Health Care Pharmaceuticals · KOSPI

Small-cap

Market cap US$156.1M (₩215.4B)

Overview

Chongkundang Holdings is a holding company, a parent entity that owns and oversees a group of operating subsidiaries, listed on KOSPI, Korea's main stock exchange.

Its business activities are conducted through those subsidiaries, which operate in the pharmaceutical and health-care space. The company's filing covers a consolidated group structure, with multiple subsidiaries consolidated into its financial reporting.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$694.9M

▲ +0.1% YoY

Operating profit · FY2025

US$42.2M

▲ +64.2% YoY

Net income · FY2025

US$39.4M

▲ +34.8% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$637.5M(₩879.8B)	US$694M(₩957.8B)	US$694.9M(₩959B)
Operating profit	US$12.3M(₩17B)	US$25.7M(₩35.5B)	US$42.2M(₩58.3B)
Net income	US$29.4M(₩40.6B)	US$29.2M(₩40.3B)	US$39.4M(₩54.3B)

Revenue

FY2023US$637.5M
FY2024US$694M
FY2025US$694.9M

Operating profit

FY2023US$12.3M
FY2024US$25.7M
FY2025US$42.2M

Net income

FY2023US$29.4M
FY2024US$29.2M
FY2025US$39.4M

Key ratios (FY2025)

ROE

6.0%

Debt/Eq

78.4%

Op. margin

6.1%

Net margin

5.7%

Rev. YoY

▲ +0.1%

Why it matters

As a holding company, it does not directly manufacture or distribute products itself; its value is tied to the performance of its underlying subsidiaries.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?